Detection and Prognostic Value of Cytokeratin Positive Tumor Cells in Bone Marrow of Patients With Renal Cell Carcinoma
- 1 November 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 170 (5) , 1747-1751
Abstract
Several investigations indicate the prognostic value of disseminated cytokeratin positive tumor cells in bone marrow of patients with carcinoma of different origin. In this study we evaluated the prognostic significance of epithelial cells in bone marrow of patients with renal cell carcinoma (RCC). Aspiration of bone marrow was performed preoperatively in 335 patients with RCC between 1990 and 1998. A total of 287 patients fulfilled all study inclusion (eg M0 R0 tumor stage) and exclusion (eg second malignancy during followup) criteria for the final analysis. Cytospin preparations were made after density gradient centrifugation of bone marrow samples and incubated with monoclonal antibodies directed against cytokeratin 18 (CK2) and pan-cytokeratin. Staining was performed using the alkaline phosphatase-anti-alkaline phosphatase method and 256 samples were evaluated. RESULTS In 25% (63 of 256) of the patients cytokeratin positive (CK+) cells were detected in bone marrow. Tumor progression (defined as tumor associated death, local recurrence or new metastases) was present in 12% (31 of 256) during the followup period (median 40 months), and 14% (9 of 63) with CK+ cells and 11% (22 of 193) with negative bone marrow status exhibited tumor progression. Survival analysis (log-rank test) showed no significant difference between the CK+ and cytokeratin negative group. The detection of CK+ cells was not an independent prognostic parameter in multivariate analysis (Cox regression model). These results indicate that the immunocytochemical detection of disseminated cytokeratin positive tumor cells in the bone marrow of patients with RCC has no prognostic significance.Keywords
This publication has 16 references indexed in Scilit:
- Combined transcriptome and genome analysis of single micrometastatic cellsNature Biotechnology, 2002
- IMMUNOMAGNETIC CELL ENRICHMENT DETECTS MORE DISSEMINATED CANCER CELLS THAN IMMUNOCYTOCHEMISTRY IN VITROJournal of Urology, 2000
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastasesThe Lancet, 1996
- Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancerNature Medicine, 1995
- Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung CarcinomaAnnals of Surgery, 1995
- Methodological Analysis of Immunocytochemical Screening for Disseminated Epithelial Tumor Cells in Bone MarrowJournal of Hematotherapy, 1994
- Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cellsHistochemistry and Cell Biology, 1993
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983